Beyond Air, Inc. Common Stock, also called Beyond Air, is a clinical-stage medical device and biopharmaceutical company. Read More It engages in the developing a nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company develops LungFit platform system, a generator and delivery system that produces nitric oxide from ambient air, eliminating the need for expensive and cumbersome cylinders. Beyond Air was founded in 2011 and is headquartered in Garden City, NY. The listed name for XAIR is Beyond Air, Inc. Common Stock.